Antibodies to kunitz domain polypeptides

Abstract

Proteinase inhibitors comprising a Kunitz domain are disclosed. The Kunitz domain comprises a sequence of amino acid residues as shown in SEQ ID NO: 5, wherein the sequence is at least 90% identical to SEQ ID NO: 2. Also disclosed are methods for making the proteinase inhibitors, and expression vectors and cultured cells that are useful within the methods. The proteinase inhibitors. may be used as components of cell culture media, in protein purification, and in certain therapeutic and diagnostic applications.

We claim:  
     
         1 . An isolated protein comprising a sequence of amino acid residues as shown in SEQ ID NO: 5, wherein said sequence is at least 90% identical to residues 9 through 59 of SEQ ID NO: 2 and wherein said protein has proteinase inhibiting activity.  
     
     
         2 . The isolated protein of  claim 1  wherein said protein is from 51 to 81 amino acid residues in length.  
     
     
         3 . The isolated protein of  claim 1  wherein said protein is from 51 to 67 residues in length.  
     
     
         4 . The isolated protein of  claim 1  wherein said sequence is selected from the group consisting of: 
 (a) residues 9 through 59 of SEQ ID NO: 2; and  
 (b) residues 9 through 59 of SEQ ID NO: 4.  
 
     
     
         5 . The isolated protein of  claim 4  wherein said protein is from 51 to 67 residues in length.  
     
     
         6 . The isolated protein of  claim 1  consisting of from 51-557 contiguous amino acid residues of SEQ ID NO: 10.  
     
     
         7 . The isolated protein of  claim 1  further comprising an affinity tag.  
     
     
         8 . The isolated protein of  claim 7  wherein said affinity tag is maltose binding protein, polyhistidine, or Glu-Tyr-Met-Pro-Met-Glu (SEQ ID NO: 18).  
     
     
         9 . An expression vector comprising the following operably linked elements: 
 (a) a transcription promoter;    (b) a DNA segment encoding a protein comprising a sequence of amino acid residues as shown in SEQ ID NO: 5, wherein said sequence of amino acid residues is at least 90% identical to residues 9 through 59 of SEQ ID NO: 2 and wherein said protein has proteinase inhibiting activity; and    (c) a transcription terminator.    
     
     
         10 . The expression vector of  claim 9  wherein said protein is from 51 to 81 amino acid residues in length.  
     
     
         11 . The expression vector of  claim 9  further comprising a secretory signal sequence operably linked to the DNA segment.  
     
     
         12 . The expression vector of  claim 9  wherein said sequence of amino acid residues is selected from the group consisting of: 
 (a) residues 9 through 59 of SEQ ID NO: 2; and  
 (b) residues 9 through 59 of SEQ ID NO: 4.  
 
     
     
         13 . The expression vector of  claim 12  wherein said protein is from 51 to 67 residues in length.  
     
     
         14 . The expression vector of  claim 9  wherein said protein is from 51 to 67 residues in length.  
     
     
         15 . The expression vector of  claim 9  wherein said DNA segment further encodes an affinity tag.  
     
     
         16 . The expression vector of  claim 15  wherein said affinity tag is maltose binding protein, polyhistidine, or Glu-Tyr-Met-Pro-Met-Glu (SEQ ID NO: 18).  
     
     
         17 . A cultured cell containing an expression vector according to  claim 9 , wherein said cell expresses the DNA segment.  
     
     
         18 . A method of making a protein having proteinase inhibiting activity comprising: 
 culturing the cell of  claim 17  under conditions whereby said DNA segment is expressed; and    recovering the protein encoded by the DNA segment.    
     
     
         19 . An antibody that specifically binds to a protein as shown in SEQ ID NO: 2 or SEQ ID NO: 4.